CD79A and COVID-19: Therefore, the comprehensive long term kinetics of SARS-CoV-2 RNA levels, anti-SARS-CoV-2 antibodies (i.e., IgA, IgM, and IgG) and specific proinflammatory cytokines during and after COVID-19 are not fully characterized, and these are of great interest for the identification of early predictive biomarkers of severe disease and to understand the clinical outcomes of patients after the remission of acute symptoms.